A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Single and Multiple Ascending Doses of GDC-0334 and the Effect of Food on the Pharmacokinetics of GDC-0334 in Healthy Adult Participants

NCT03381144 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

66

Enrollment

INDUSTRY

Sponsor class

Stopped Molecule development was terminated

Conditions

Healthy Volunteers

Interventions

DRUG: GDC-0334
DRUG: Placebo

Sponsor

Genentech, Inc.